Columbia Research Enhanced Value ETFREVS
Type
ETF
Peer group
US equity: large companies
Net assets
$283.7M
Expense ratio
0.19%
1-year return
+25.0%
3 years, a year
+19.8%
5 years, a year
+12.3%
12-month yield
1.82%
Holdings
310
What it aims to do.
Columbia Research Enhanced Value ETF (the Fund) seeks investment results that, before fees and expenses, closely correspond to the performance of the Beta Advantage Research Enhanced U.S. Value Index (the Index).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| XOM Exxon Mobil Corp | 3.48% |
| PG Procter & Gamble Co/The | 3.30% |
| WFC Wells Fargo & Co | 3.26% |
| GOOGL Alphabet Inc | 3.25% |
| CSCO Cisco Systems Inc | 3.01% |
| GOOG Alphabet Inc | 2.63% |
| C Citigroup Inc | 2.31% |
| PFE Pfizer Inc | 2.23% |
| AMD Advanced Micro Devices Inc | 1.96% |
| CVX Chevron Corp | 1.93% |
More on REVS.
- REVS overview
- REVS holdings
- REVS risk
- REVS costs
- REVS money in and out
- REVS share classes
- Compare REVS with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.